According to the results of the “Ukrainian People’s Award” rating, the drug “Atoxil” was recognized as the leader in the “Best Sorbent 2014” nomination.
The Ukrainian National Award is the first and only all-Ukrainian national project whose main purpose is to optimize the national market of goods and services by identifying its best representatives on the basis of popular voting.

Therapeutic efficacy of the drug Attoxil:

  • elimination of intoxication and poisoning expression (nausea, vomiting, weakness, digestive disorders)
  • elimination of stomach and intestinal disorders (diarrhea, bloating, dysbiosis)
  • reduction of toxic-allergic reactions, elimination of skin allergy, itching expression
  • elimination of intoxication syndrome in the liver and kidneys diseases


Recommendations for use:

  • acute intestinal infections
  • food poisoning
  • diarrhea
  • dysbiosis
  • food allergic diseases (atopic dermatitis, urticaria, diathesis)
  • dermatological diseases (psoriasis, eczema, dermatitis)
  • liver disease (acute and chronic)
  • chronic renal failure, pyelonephritis


Atoxil – a drug with a high safety profile, it is not split and is not absorbed in the gastrointestinal tract. Therefore, it is recommended for all patient groups since the first year of life.
Atoxil has been registered as a drug that has undergone all stages of clinical trials and has confirmed its high efficacy and safety in use.

Silicon dioxide, part of the drug Atoxil, manufactured by Orisil-Pharm, was tested for compliance with FDA and US Pharmacopoeia standards with USP 29-NF24 monograph tests.